Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia

10.3988/jcn.2021.17.3.376

Saved in:

Bibliographic Details
Main Authors:	Park, Kee Hyung, Yang, YoungSoon, Chen, Christopher, Shim, Yong S, Domingueze, Jacqueline C, Lee, Chan-Nyoung, Kang, Kyunghun, Kim, Hee-Jin, Jeong, Seul-Ki, Jeong, Jee Hyang, Hong, Zhen, Yoon, Soo Jin, Zhang, Zhen-Xin, Kim, Eun-Joo, Jang, Jae-Won, Li, Yansheng, Xu, Yun, Lin, Yu-Te, Qu, Qiumin, Hu, Chaur-Jong, Chou, Chih-Ho, Fan, Dongsheng, Kandiah, Nagaendran, Yang, Yuan-Han, Lau, Chi-ieong, Chu, Leung-Wing, Wang, Huali, Jung, San, Choi, Seong Hye, Kim, SangYun
Other Authors:	PHARMACOLOGY
Format:	Article
Language:	English
Published:	KOREAN NEUROLOGICAL ASSOC 2022
Subjects:	Science & Technology Life Sciences & Biomedicine Clinical Neurology Neurosciences & Neurology Alzheimer's disease Asia cognition donepezil LONG-TERM EFFICACY DOUBLE-BLIND CHOLINESTERASE-INHIBITORS US MULTICENTER OPEN-LABEL SAFETY PERSISTENCE ADHERENCE MODERATE DEMENTIA
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/218741
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

Description
Summary:	10.3988/jcn.2021.17.3.376